Shield Therapeutics' IPO

Shield Therapeutics raised a round of funding on February 17, 2016. Investors include Public.

Shield Therapeutics is focused on the development and commercialization of therapies to treat rare diseases or those with significant unmet medical need. Shield Therapeutics' lead development candidat…

Articles about Shield Therapeutics' IPO: